Press releases

Transaction creates increased clinical and economic value for 11,500 specialty providers, including more than 7,000 physicians across 1,200 independent physician practices Transaction creates...

Progress achieved on company's ongoing business and portfolio review Completed review of growth businesses within the Medical Segment: investing in and further developing at-Home Solutions and...

Cardinal Health (NYSE: CAH) plans to release second-quarter financial results for its fiscal year 2024 on February 1, prior to the opening of trading on the New York Stock Exchange. The company...

Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.5006 per share out of the Company's capital surplus. The dividend will be payable on...

SmartGown™ EDGE is the first pocketed surgical gown designed to help maintain instrument sterility and accessibility. DUBLIN, Ohio, Nov. 9, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH)...

Revenue increased 10% to $54.8 billion GAAP1 operating loss was $14 million and GAAP diluted EPS was $0.02, driven by a Medical segment goodwill impairment Non-GAAP operating earnings increased 35% to

Cardinal Health (NYSE: CAH) has been named among the 100 Best Corporate Citizens, a prestigious annual ranking by 3BL Media that assesses the environmental, social and governance (ESG)...

The next generation in enteral feeding, Kangaroo OMNI™ delivers nutrition and hydration from hospital to home. DUBLIN, Ohio, Sept. 28, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced...

Cardinal Health (NYSE: CAH) plans to release first-quarter financial results for its fiscal year 2024 on November 3, prior to the opening of trading on the New York Stock Exchange. The company...

Cardinal Health Foundation will invest $1.7M to help 14 children's hospitals nationwide prevent youth suicide. DUBLIN, Ohio, Sept. 13, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH) in...

The NTrainer™ System 2.0 is the only FDA Class II biofeedback device designed to help newborns and infants born prematurely develop their non-nutritive sucking skills needed for independent oral...

Fourth quarter revenue increased 13% to $53.5 billion Fourth quarter GAAP1 operating earnings were $137 million and GAAP diluted loss per share was $0.25 Fourth quarter non-GAAP operating earnings...

Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.5006 per share out of the Company's capital surplus. The dividend will be payable on...

Cardinal Health (NYSE: CAH) plans to release fourth-quarter and year-end financial results for its fiscal year 2023 on August 15, prior to the opening of trading on the New York Stock Exchange....

New facility is the largest at-Home Solutions has built to date, set to accommodate continued business and home healthcare industry growth DUBLIN, Ohio, June 15, 2023 /PRNewswire/ -- Cardinal...

Narrowing fiscal year 2023 non-GAAP diluted EPS guidance to $5.65 to $5.80, from $5.60 to $5.80 (13% growth at the mid-point)1 Providing preliminary fiscal year 2024 non-GAAP diluted EPS guidance...

Cardinal Health's Outcomes™ business will combine with Transaction Data Systems to offer improved patient engagement and clinical pharmacy solutions, expanding connections between payers and...

Cardinal Health (NYSE: CAH) today launched modern payment solutions, powered by Square, to help independent pharmacies increase operational efficiency, stay current with customer payment...

Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved an increase to the Company's quarterly dividend, to $0.5006 per share, out of the Company's capital surplus. The...

Revenue increased 13% to $50.5 billion GAAP1 operating earnings were $572 million; GAAP diluted EPS was $1.34 Non-GAAP operating earnings increased 11% to $606 million; non-GAAP diluted EPS...

The new facilities represent Cardinal Health's ongoing commitment to servicing customers, warehousing modernization and growing the local economy DUBLIN, Ohio, April 17, 2023 /PRNewswire/ --...

Cardinal Health (NYSE: CAH) plans to release third-quarter financial results for its fiscal year 2023 on May 4, prior to the opening of trading on the New York Stock Exchange. The company will...

Cardinal Health (NYSE:CAH) today announced its collaboration with Signify Health (NYSE:SGFY) to offer in-home clinical and medication management services through its Outcomes™ business. This...

Study reveals provider perceptions of commercially available biosimilars and anticipated launches, which have the potential to increase equitable access to critical treatments DUBLIN, Ohio, Feb....

Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.4957 per share out of the Company's capital surplus. The dividend will be payable on...

Revenue increased 13% to $51.5 billion GAAP1 operating loss was $119 million due to a non-cash, pre-tax goodwill impairment of $709 million related to the Medical segment; GAAP diluted loss per...

The platform will combine and analyze datasets for live purchasing decision support of pharmaceuticals DUBLIN, Ohio and DENVER, Jan. 26, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced...

Cardinal Health (NYSE: CAH) plans to release second-quarter financial results for its fiscal year 2023 on February 2, prior to the opening of trading on the New York Stock Exchange. The company...

Cardinal Health (NYSE: CAH) and its board of directors announced today that Aaron Alt will become the company's new chief financial officer (CFO). Alt will succeed interim CFO, Trish English and...

Cardinal Health (NYSE: CAH) released today its latest edition of Oncology Insights, a biannual, research-based report from Cardinal Health. Featuring perspectives from nearly 200 oncologists...

Launching as a pilot with Medically Home, new technology offering will reach patients in one to two hours DUBLIN, Ohio, Nov. 15, 2022 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced...

Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.4957 per share out of the Company's capital surplus. The dividend will be payable on...

Revenue increased 13% to $49.6 billion GAAP1 operating earnings were $137 million, GAAP diluted EPS were $0.40 Non-GAAP operating earnings decreased 20% to $423 million due to a decline in Medical...

Today, Cardinal Health (NYSE: CAH) released its third edition of Rheumatology Insights, a research report based on surveys with more than 100 rheumatologists nationwide that focuses on key trends...

Cardinal Health (NYSE: CAH) plans to release first-quarter financial results for its fiscal year 2023 on November 4, prior to the opening of trading on the New York Stock Exchange. The company...

--Victor Crawford will step down as CEO of Pharmaceutical Segment-- --Debbie Weitzman, President of Pharmaceutical Distribution, named CEO of Pharmaceutical Segment-- DUBLIN, Ohio, Sept. 8, 2022...

Adds Four New Independent Directors to the Board Forms New Business Review Committee to Evaluate Portfolio and Operations DUBLIN, Ohio, Sept. 6, 2022 /PRNewswire/ -- Cardinal Health (NYSE: CAH)...

Revenue increased 11% to $47.1 billion in the fourth quarter GAAP1 operating earnings were $36 million in the fourth quarter; GAAP diluted EPS were $0.50 in the fourth quarter Non-GAAP operating...

-- Mike Kaufmann to Step Down as Chief Executive Officer and from Board of Directors -- -- Jason Hollar, Chief Financial Officer, Named Chief Executive Officer -- -- Patricia English to Serve as...

Greene previously served as SVP of EIT for the company's Pharmaceutical Segment DUBLIN, Ohio, Aug. 1, 2022 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that Michelle Greene has been...

TO: ALL PERSONS AND ENTITIES THAT HELD CARDINAL HEALTH, INC. COMMON STOCK AS OF THE CLOSE OF TRADING ON MAY 25, 2022 AND THAT CONTINUE TO HOLD CARDINAL HEALTH COMMON STOCK AS OF THE CLOSE OF...

Cardinal Health (NYSE: CAH) plans to release fourth-quarter and year-end financial results for its fiscal year 2022 on August 11, prior to the opening of trading on the New York Stock Exchange....

Strengthening Cornerstone Rheumatology™ GPO as a leading rheumatology-focused GPO by providing innovative solutions and robust specialty drug access to over 1,300 rheumatology providers nationwide.

Cardinal Health (NYSE: CAH) today announced the launch of an inventory reserve program that helps labs and health systems more accurately pre-order respiratory diagnostics before the onset of...

Research shows stress leading oncologists to consider leaving the field, retiring or selling their practice DUBLIN, Ohio, June 3, 2022 /PRNewswire/ -- Nearly 90% of oncologists said they...

New facility to operate state-of-the-art warehouse technology, while creating new jobs DUBLIN, Ohio, June 2, 2022 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced the addition of a new...

Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.4957 per share out of the Company's capital surplus. The dividend will be payable on...